This compound is a pharmaceutical intermediate used in the synthesis of Olaparib, a poly(ADP-ribose) polymerase (PARP) inhibitor. It exhibits structural features including aromatic rings, a nitrile group, and an ester-containing heterocycle.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-Fluoro-5-(4-oxo-3,4-dihydrophthalazin-1-ylmethyl)benzoic acid
pharmaceutical intermediate
N-alpha-Boc-D-2,3-diaminopropionic acid
pharmaceutical intermediate
2-butyn-1-ol
pharmaceutical intermediate
Biisocrotyl
pharmaceutical intermediate
3-[(4-Chlorophenyl)methylidene]-2-benzofuran-1(3H)-one
pharmaceutical intermediate
2-fluoro-5-[(3-oxo-2-benzofuran-1-ylidene)methyl]benzonitrile
MMPHWTMMVPBHRZ-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(=CC3=CC(=C(C=C3)F)C#N)OC2=O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.